Operating
Stock-Based Comp
CME Group Stock-Based Comp decreased by 24.6% to $21.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.8%, from $21.20M to $21.80M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 6.0% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.40M | $15.60M | $18.60M | $20.00M | $19.40M | $19.40M | $25.50M | $20.20M | $19.50M | $18.90M | $24.30M | $23.30M | $18.80M | $20.30M | $27.10M | $21.20M | $20.70M | $24.00M | $28.90M | $21.80M |
| QoQ Change | — | -19.6% | +19.2% | +7.5% | -3.0% | +0.0% | +31.4% | -20.8% | -3.5% | -3.1% | +28.6% | -4.1% | -19.3% | +8.0% | +33.5% | -21.8% | -2.4% | +15.9% | +20.4% | -24.6% |
| YoY Change | — | — | — | — | +0.0% | +24.4% | +37.1% | +1.0% | +0.5% | -2.6% | -4.7% | +15.3% | -3.6% | +7.4% | +11.5% | -9.0% | +10.1% | +18.2% | +6.6% | +2.8% |
Range$15.60M – $28.90M
CAGR+2.5%
Avg YoY Growth+7.2%
Median YoY Growth+4.7%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is CME Group's stock-based comp?
- CME Group (CME) reported stock-based comp of $21.80M in Q1 2026.
- How has CME Group's stock-based comp changed year-over-year?
- CME Group's stock-based comp increased by 2.8% year-over-year, from $21.20M to $21.80M.
- What is the long-term trend for CME Group's stock-based comp?
- Over 4 years (2021 to 2025), CME Group's stock-based comp has grown at a 6.0% compound annual growth rate (CAGR), from $75.20M to $94.80M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.